OUR PRIMARY MISSION INCLUDES FUNDING RESEARCH TO FIND A CURE OR TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY. WE ARE COMMITTED TO SAVING THIS GENERATION OF CHILDREN. WHEN WE WORK SMART, LEVERAGE EACH DOLLAR AND WORK IN CLOSE PARTNERSHIP WITH SCIENTISTS AND RESEARCH COMPANIES, THERE IS THE PROMISE FOR AN END TO DUCHENNE. WE ARE PROUD THAT 2 PROJECTS WE'VE SUPPORTED IN EARLY STAGES ARE NOW IN CLINCIAL TRIAL, AND ONE IS UNDER REVIEW FOR FDA APPROVAL. IN THE MEANTIME, WHILE WE FIGHT FOR THE FUTURE FOR THESE BOYS, WE ARE COMMITTED TO BEING THERE FOR THEM AND HELPING FAMILIES RIGHT NOW IN THE PRESENT MOMENT.
Executive compensation
Form 990 · Schedule J · 2 reported individuals · Filing year 2023
| Base salary | Executive compensation | |
|---|---|---|
Plus 5 unpaid individuals.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.